Multiomics – News and Features

Emory study reveals how a highly successful vaccine triggers robust immune responses.

The assay products for low to mid-plex applications will strengthen company's position in high-growth validation and routine-testing markets.

Evonik will use the ERGO™ system to optimize their production strains and find new methods for high yield production of specialty chemicals.

Scientists to apply novel techniques to study diseases that include severe acute respiratory syndrome (SARS), tuberculosis and influenza.

GeneGo will collaborate with FDA to develop a platform for understanding the influence of nutrients on cancerogenesis and cancer prevention.

Scientists have found a way to quickly and reversibly fine-tune the activity of individual proteins in cells and living mammals.

Understanding biology at the systems level is difficult, especially when studying complex specimens like tissue slices or communities of organisms in a biofilm.

Cellumen will use its proprietary CellCiphr® toxicity risk assessment technology to profile blinded samples of known liver toxicity compounds.

The agreement provides Merck with access to GeneGo's content through MetaBase and GeneGo's internal database of disease biomarkers.

Researchers uncovered new evidence that a network of influential genes acts as a kind of genetic tag team to the cell cycle.